This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ellen Margaret Knapp: Innovator in Cancer Treatment
Introduction: Ellen Margaret Knapp is a notable inventor based in Lafayette, Colorado, whose contributions to pharmaceutical science have garnered attention. With a focus on combating abnormal cell growth, including cancer, her innovative work exemplifies the critical intersection of research and real-world application within the pharmaceutical industry.
Latest Patents: Ellen holds a patent for a compound known as 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones, which serves as a MEK inhibitor. This invention incorporates a compound of Formula I or its pharmaceutically acceptable salt, targeting the treatment of abnormal cell growth. The patent also covers various pharmaceutical compositions and methods involving these compounds, highlighting their potential in cancer therapy.
Career Highlights: Ellen is currently employed at Pfizer Corporation, a leader in the global pharmaceutical industry, where she applies her expertise in drug development. Her work is a testament to the impactful role that innovation plays in addressing critical health challenges faced by society.
Collaborations: Throughout her career, Ellen has collaborated with esteemed colleagues Shelley Allen and Patrick Michael Doerner Barbour. These partnerships are instrumental in fostering a dynamic environment for innovative research and development, enabling advances in cancer treatment solutions.
Conclusion: Ellen Margaret Knapp's contributions to the field of pharmaceuticals not only reflect her inventive spirit but also underscore the importance of collaboration in advancing scientific discovery. Her patent for a MEK inhibitor illustrates a meaningful step toward more effective cancer treatments, showcasing the vital role of inventors in transforming healthcare.